228 related articles for article (PubMed ID: 17705018)
1. Airway complication occurring during radioiodine treatment for Graves' disease.
Kinuya S; Yoneyama T; Michigishi T
Ann Nucl Med; 2007 Aug; 21(6):367-9. PubMed ID: 17705018
[TBL] [Abstract][Full Text] [Related]
2. Administration of additional inactive iodide during radioiodine therapy for Graves' disease: who might benefit?
Dietlein M; Moka D; Reinholz U; Schmidt M; Schomäcker K; Schicha H; Wellner U
Nuklearmedizin; 2007; 46(3):77-84. PubMed ID: 17549318
[TBL] [Abstract][Full Text] [Related]
3. [Radioiodine therapy of Graves' disease--quality assurance and radiation protection].
Reiners C
Z Arztl Fortbild Qualitatssich; 1999 Apr; 93 Suppl 1():61-6. PubMed ID: 10355053
[TBL] [Abstract][Full Text] [Related]
4. A predictive mathematical model for the calculation of the final mass of Graves' disease thyroids treated with 131I.
Traino AC; Di Martino F; Grosso M; Monzani F; Dardano A; Caraccio N; Mariani G; Lazzeri M
Phys Med Biol; 2005 May; 50(9):2181-91. PubMed ID: 15843745
[TBL] [Abstract][Full Text] [Related]
5. Iodine prophylaxis intensification. Influence on radioiodine uptake and activity of 131I used in the treatment of hyperthyroid patients with Graves' disease.
Baczyk M; Junik R; Ziemnicka K; Sowiński J
Nuklearmedizin; 2005; 44(5):197-9. PubMed ID: 16395495
[TBL] [Abstract][Full Text] [Related]
6. [Radioiodine treatment in Basedow's disease].
Rösler H
Schweiz Med Wochenschr; 1976 Sep; 106(36):1215-8. PubMed ID: 1036630
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of radioiodine 131I treatment in Graves' disease patients with mild orbitopathy].
Bałdys-Waligórska A; Stefańska A; Gołkowski F; Sokołowski G; Hubalewska-Dydejczyk A
Przegl Lek; 2009; 66(4):166-9. PubMed ID: 19708504
[TBL] [Abstract][Full Text] [Related]
8. [Radioiodine therapy for women with Graves' disease and the risk of foetal hypothyroidism if they are later found to be pregnant].
Prinsen AK; Jansen J; Bakker WH; Wildschut HI
Ned Tijdschr Geneeskd; 2006 Dec; 150(52):2845-8. PubMed ID: 17319213
[TBL] [Abstract][Full Text] [Related]
9. Correlation of stress with outcome of radioiodine therapy for Graves' disease.
Stewart T; Rochon J; Lenfestey R; Wise P
J Nucl Med; 1985 Jun; 26(6):592-9. PubMed ID: 3839012
[TBL] [Abstract][Full Text] [Related]
10. Radioiodine associated de novo Graves' opthalmopathy in an Asian cohort.
Tay WL; Tong AKT; Hui KYD; Tang YLC; Chng CL
Hell J Nucl Med; 2017; 20(3):227-231. PubMed ID: 29177260
[TBL] [Abstract][Full Text] [Related]
11. The role of nuclear medicine in the management of Graves' disease.
Freitas JE
Q J Nucl Med; 1999 Dec; 43(4):297-306. PubMed ID: 10731780
[TBL] [Abstract][Full Text] [Related]
12. Incidence of hypothyroidism following small doses of 131I in the treatment of Graves' disease.
McCullagh EP; Jelden GL; Rodriguez-Antunez A
Ohio State Med J; 1976 Sep; 72(9):538-40. PubMed ID: 989600
[No Abstract] [Full Text] [Related]
13. [Graves' disease nd toxic nodular goiter--radioiodine therapy].
Schicha H; Dietlein M
Nuklearmedizin; 2002 Apr; 41(2):63-70. PubMed ID: 11989300
[TBL] [Abstract][Full Text] [Related]
14. Incidence of radioiodine induced Graves' disease in patients with multinodular toxic goiter.
Meller J; Siefker U; Hamann A; Hüfner M
Exp Clin Endocrinol Diabetes; 2006 May; 114(5):235-9. PubMed ID: 16804797
[TBL] [Abstract][Full Text] [Related]
15. Iodine-131 treatment of Graves' disease using modified early iodine-131 uptake measurements in therapy dose calculations.
Hayes AA; Akre CM; Gorman CA
J Nucl Med; 1990 Apr; 31(4):519-22. PubMed ID: 2324829
[TBL] [Abstract][Full Text] [Related]
16. Influence of short-term interruption of antithyroid drugs on the outcome of radioiodine therapy of Graves' disease: results of a prospective study.
Eschmann SM; Thelen MH; Dittmann H; Bares R
Exp Clin Endocrinol Diabetes; 2006 May; 114(5):222-6. PubMed ID: 16804795
[TBL] [Abstract][Full Text] [Related]
17. Does radioiodine cause the ophthalmopathy of Graves' disease?
McDougall IR
Nucl Med Commun; 1993 Feb; 14(2):79-81. PubMed ID: 8429998
[No Abstract] [Full Text] [Related]
18. What influences early hypothyroidism after radioiodine treatment for Graves' hyperthyroidism?
Vijayakumar V; Ali S; Nishino T; Nusynowitz M
Clin Nucl Med; 2006 Nov; 31(11):688-9. PubMed ID: 17053385
[TBL] [Abstract][Full Text] [Related]
19. International differences in approaches to 131I therapy for Graves' disease: case selection and restrictions recommended to patients in Japan, Korea, and China.
Tominaga T; Yokoyama N; Nagataki S; Cho BY; Koh CS; Chen JL; Shi Y
Thyroid; 1997 Apr; 7(2):217-20. PubMed ID: 9133688
[TBL] [Abstract][Full Text] [Related]
20. Radioiodine treatment of Graves' disease. An assessment of its potential risks.
Graham GD; Burman KD
Ann Intern Med; 1986 Dec; 105(6):900-5. PubMed ID: 3777715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
